Investors considering a purchase of Halozyme Therapeutics Inc (HALO) shares, but cautious about paying the going market price of $6.62/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $5 strike, which has a bid at the time of this writing of 50 cents. Collecting that bid as the premium represents a 10% return against the $5 commitment, or a 33.2% annualized rate of return (at Stock Options Channel we call this the YieldBoost).
Commit To Purchase Halozyme Therapeutics At $5, Earn 33.2% Annualized
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts